Live Breaking News & Updates on Uveal melanoma in molecular cancer research

Stay updated with breaking news from Uveal melanoma in molecular cancer research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

LA JOLLA, Calif., May 20, 2024 MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the Standard Market of the Tokyo Stock Exchange , today announced that it has. ....

Tokyo , Japan , Kazuko-matsuda , Davidh-crean , Trademark-office , Nasdaq , Medicinova-inc , Uveal-melanoma-in-molecular-cancer-research , Exchange-commission , Standard-market , Tokyo-stock-exchange , Code-number

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo , Japan , Davidh-crean , Kazuko-matsuda , Nasdaq , Uveal-melanoma-in-molecular-cancer-research , Medicinova-inc , Exchange-commission , Trademark-office , Nova-receives-notice , New-patent-covering , Standard-market